PE Audit and Feedback Intervention for Cardiovascular Diseases

Phase-Based Progress Estimates
UC Berkeley, Berkeley, CA
Cardiovascular Diseases+1 More
PE Audit and Feedback Tool - Behavioral
Any Age
All Sexes
What conditions do you have?

Study Summary

School physical education (PE) is one of the most valuable tools for increasing physical activity and fitness among youth of all backgrounds; however, compliance with existing PE laws is low (and differential by school race/ethnic and family-income composition, contributing to health disparities), and best practices for increasing compliance remain unknown. This study proposes to examine a novel approach for increasing PE law compliance by testing a PE audit and feedback tool (adapted from a tool used by the New York City Department of Education) in Oakland, California schools to determine the effectiveness, adaptability, and scalability of this potential cost-effective approach for increasing PE law compliance and student physical activity.

Eligible Conditions

  • Physical Inactivity
  • Cardiovascular Diseases

Treatment Effectiveness

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: 20-30 minutes

20-30 minutes
Week 12

Trial Safety

Trial Design

2 Treatment Groups

PE Support as Usual
1 of 2
PE Audit and Feedback Intervention
1 of 2
Active Control
Experimental Treatment

8 Total Participants · 2 Treatment Groups

Primary Treatment: PE Audit and Feedback Intervention · No Placebo Group · N/A

PE Audit and Feedback Intervention
Experimental Group · 1 Intervention: PE Audit and Feedback Tool · Intervention Types: Behavioral
PE Support as UsualNoIntervention Group · 1 Intervention: PE Support as Usual · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 20-30 minutes

Trial Background

Prof. Hannah R. Thompson, Assistant Research Professor
Principal Investigator
University of California, Berkeley
Closest Location: UC Berkeley · Berkeley, CA
2018First Recorded Clinical Trial
1 TrialsResearching Cardiovascular Diseases
1 CompletedClinical Trials

Eligibility Criteria

Age Any Age · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.